1
Memantine for Epileptic Encephalopathy
Condition(s):Epileptic Encephalopathy, Childhood-OnsetLast Updated:May 1, 2020Recruiting
Memantine Hydrochloride: 234 Clinical Trials, Page 1 of 24
Hide Studies Not Open or Pending
2
Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects
Condition(s):SchizophreniaLast Updated:December 14, 2015Unknown status
3
Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
Condition(s):Bipolar DisorderLast Updated:October 3, 2019Recruiting
4
Down Syndrome Memantine Follow-up Study
Condition(s):Down Syndrome; Intellectual DisabilityLast Updated:July 28, 2020Completed
5
Memantine Treatment in Alzheimer’s Disease Patients
Condition(s):Alzheimer DiseaseLast Updated:May 30, 2017Unknown status
6
Effect of Memantine on Cognitive Impairment in Patients With Epilepsy
Condition(s):EpilepsyLast Updated:June 4, 2020Completed
7
Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
Condition(s):Malignant Central Nervous System Neoplasm; Primary Central Nervous System NeoplasmLast Updated:May 14, 2020Recruiting
8
A Phase – IIa – IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD
Condition(s):Sickle Cell DiseaseLast Updated:November 1, 2019Recruiting
9
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger’s Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Condition(s):Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger’s Disorder; Asperger’s; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)Last Updated:August 7, 2014Completed
10
Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy
Condition(s):Autism Spectrum DisorderLast Updated:March 25, 2020Recruiting